Table 1

Data extraction framework

BibliometricsOriginal trial characteristicsFollow-up trial characteristics
AuthorsTrial nameTime since trial closure
TitleCountry of origin
Year of publicationOriginal authors (differ from follow-up study's authors?)Data sources for follow-up outcomes (eg, health administrative, population registry, EMRs). Linkages fields and type linkage (probabilistic/deterministic); where was linkage conducted (eg, academic, government body, etc)?
Publication sourceOutcomes (primary and secondary)Outcomes (primary and secondary); identification of extended trial outcomes: structured data (eg, claims data); unstructured data—information contained in text (eg, EMR) or other documents; technique used for extracting information: manual, text mining
Journal impact (low/high)Timeframe
Intervention applied
Potential/realised clinical or policy implicationsWere the conclusions of the original trial altered?
FundersPotential/realised clinical or policy implications; for example, evidence supporting or against current guidelines
 Comments regarding ethics approval
Funders
Challenges, time requirements and costs associated with extension
Methodological issues (eg, unadjusted time-varying confounding)
Stated reasons for trial extension (eg, long-term treatment effects, potential ‘legacy’ effects)
  • EMR, electronic medical record.